the First Line Treatment
1 clinical trials · Condition
◉ Watch the First Line Treatment
| Record | Firm | Date |
|---|---|---|
| Combination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in Unresectable Gallbladder Cancer (NCT05757336) | Lu Wang, MD, PhD | 2022-12-22 |
Track the First Line Treatment automatically
Every clearance here is in the API, with alerts when new ones post.